Ascher NL, Lake JR, Emond JC, et al. Liver transplantation for fulminant hepatic failure. Arch Surg 1993; 128:677-82.

Blei AT, Olafsson S, Webster S, Levy R. Complications of intracranial pressure monitoring in fulminant hepatic failure. Lancet 1993; 341:157-8. O'Grady JG, Alexander GJ, Hayllar KM, et al. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology 1989; 97:439-45.

Bernuau J, Rueff B, Benhamou JP. Fulminant and subfulminant liver failure: definitions and causes. Sem in Liver Disease 1986; 6:97-106.

O'Grady JG, Gimson AE, O'Brien CJ, et al. Controlled trials of charcoal hemoperfusion and prognostic factors in fulminant hepatic failure. Gastroenter-ology 1988; 94:1186-92.

Stange J, Ramlow W, Mitzner S, et al. Dialysis against a recycled albumin solution enables the removal of albumin-bound toxins. Artif Organs 1993; 17:809-13. Weber C, Rajnoch C, Loth F, et al. The microspheres based detoxification system (MDS). A new extracorporeal blood purification procedure based on recirculated microspherical absorbent particles. Int J Artif Organs 1994; 17:595-602. Rozga J, Podesta L, LePage E, et al. A bioartificial liver to treat severe acute liver failure. Ann Surg 1994; 219:538-46.

Sussman NL, Gislason GT, Conlin CA, Kelly JH. The Hepatix extracorporeal liver assist device: initial clinical experience. Artif Organs 1994; 18:390-96. Fox, IJ, Langnas AN, Fristoe LW, et al. Successful application of extracorporeal liver perfusion: a technology whose time has come. Am J Gastroenterol 1993; 88:1876-81. Chari RS, Collins BH, Magee JC, et al. Brief report: treatment of hepatic failure with ex vivo pig-liver perfusion followed by liver transplantation. N Engl J Med 1994; 331:234-7.

Harland RC, Platt JL. Prospects for xenotransplantation of the liver. J Hepatol 1996; 25:248-58.

Coy D., Blei AT. Portal hypertension. In: Berk J, Schaffner F, eds. Bockus Textbook of Gastroenterology. Philadelphia: Saunders, 1994:1955-87.

Cordoba J, Blei AT. Treatment of hepatic encephalopathy. Am J Gastroenterol 1997;


Chari RS, Gan TJ, Robertson KM, Bass K, Camargo CA Jr, Greig PD, Clavien PA. Venovenous bypass in adult orthotopic liver transplantation: routine or selective use? J Am Coll Surg 1998; 186:683-90.

Ferraz-Neto BH, Mirza DF, Gunson BK, et al. Bile duct splintage in liver transplantation: is it necessary? Transplant International 1996; 9 Supp.1:S185-7. Clavien PA, Harvey PR, Strasberg SM. Preservation and reperfusion injuries in liver allografts. An overview and synthesis of current studies. Transplantation 1992; 53:957-78.

Reyes J, Gerber D, Mazariegos GV, et al. Split-liver transplantation: a comparison of ex vivo and in situ techniques. J Ped Surg 2000; 35:283-9.

Ghobrial RM, Yersiz H, Farmer DG, et al. Predictors of survival after in vivo split liver transplantation: analysis of 110 consecutive patients. Ann Surg 2000;


Greig PD, Woolf GM, Sinclair SB, et al. Treatment of primary liver graft nonfunction with prostaglandin Ej. Transplantation 1989; 48:447-53.

Abbasoglu O, Levy MF, Testa G, et al. Does intraoperative hepatic artery flow predict arterial complications after liver transplantation? Transplantation 1998; 66:598-601.

Douzdjian V, Abecassis MM, Johlin FC. Sphincter of Oddi dysfunction following liver transplantation: screening by bed-side manometry and definitive manomet-ric evaluation. Dig Dis Sci 1994; 39:253-6.

0 0

Post a comment